Adjuvant nivolumab for oesophageal cancer (ID1676)

£656.3K GBP

Funder	National Institute for Health Research
Recipient Organization	The University of Sheffield
Country	United Kingdom
Start Date	Mar 16, 2021
End Date	Sep 07, 2021
Duration	175 days
Number of Grantees	1
Roles	Award Holder
Data Source	Europe PMC
Grant ID	`NIHR133714`

Grant Description

To appraise the clinical and cost effectiveness of nivolumab within its marketing authorisation for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer.